Is BBLG research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BBLG. It does not provide personalized investment advice.

BBLG (Bone Biologics Corp Common Stock) Stock Analysis - Financials

Bone Biologics Corp Common Stock (BBLG) is a publicly traded Healthcare sector company. As of September 17, 2026, BBLG trades at $0.48 with a market cap of $1.49M and a P/E ratio of -0.20. BBLG moved +0.00% today. Year to date, BBLG is -62.92%; over the trailing twelve months it is -74.88%. Its 52-week range spans $0.51 to $7.74. Rallies surfaces BBLG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are BBLG's key financials?

BBLG financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BBLG recently traded at $0.48. Market cap is $1.49M. P/E ratio is -0.20. Revenue is $0.

BBLG Key Metrics

Key financial metrics for BBLG
Metric	Value
Price	$0.48
Market Cap	$1.49M
P/E Ratio	-0.20
EPS	$-2.65
Dividend Yield	0.00%
52-Week High	$7.74
52-Week Low	$0.51
Volume	13.95K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-3.10M
Gross Margin	0.00%

BBLG Analyst Consensus

BBLG analyst coverage data. Average price target: $0.00.

Common questions about BBLG

What are BBLG's key financials?: BBLG financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BBLG recently traded at $0.48. Market cap is $1.49M. P/E ratio is -0.20. Revenue is $0.
Is BBLG research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BBLG. It does not provide personalized investment advice.